PTPA and familial dilated cardiomyopathy: However, the role of mAKAPβ-bound PP2A in promoting pathological eccentric hypertrophy suggests that targeting of mAKAPβ-PP2A perinuclear signalosomes may be also beneficial in DCM disease.